Boehringer Ingelheim Pharmaceuticals Revenue, Growth & Competitor Profile

DBA BOEHRINGER INGELHEIM CORPORATION
DBA BOEHRINGER INGELHEIM ROXANE, INC.
DBA BOEHRINGER INGELHEIM USA CORPORATION

Company Profile & Annual Report for Boehringer Ingelheim Pharmaceuticals

Access the complete profile.

Boehringer Ingelheim Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	900 Ridgebury Rd Ridgefield, CT 06877

Note: Revenues for privately held companies are statistical evaluations.


Boehringer Ingelheim Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Boehringer Ingelheim Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Boehringer Ingelheim Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Boehringer Ingelheim Pharmaceuticals Annual Revenue and Growth Rate

Boehringer Ingelheim Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Boehringer Ingelheim Pharmaceuticals's revenues are gauged from an analysis of company filings.

Boehringer Ingelheim Pharmaceuticals's Income Statement (based on Industry Averages)

Boehringer Ingelheim Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Boehringer Ingelheim Pharmaceuticals is developing and marketing. Boehringer Ingelheim Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LUNG LOYALTY Promoting public awareness of lung diseases and conditions and their symptoms, prevention and treatment; business administration of an incentive program for patients to earn points that are redeemable for health-related items; providing patients with consumer product information concerning various brands of pharmaceuticals to encourage prescription medication adherence	05/16/2023
NEXTGEN STAR conducting a competition for identifying top students with an interest in pharmaceutical research and development; educational services in the nature of an immersive educational experience, including presentations, training, classes, seminars, workshops, lectures, demonstrations, educational speakers and internships, all in the field of pharmaceutical research and development	04/06/2023
CUIDE SU CORAZÓN promoting awareness of diabetes, heart disease and heart failure, and their symptoms, treatment and prevention	07/21/2022

See all trademarks and details in the Full Report.

Market Share of Boehringer Ingelheim Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Boehringer Ingelheim Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Boehringer Ingelheim Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BOEHRINGER INGELHEIM PHARMACEUTICALS	Ridgefield, CT	100
TRIRX PHARMACEUTICAL SERVICES	Norwalk, CT	4
ZARBEE'S	Greenwich, CT	0
RADD PHARMACEUTICALS	Westport, CT	0
MD SOLARSCIENCES	Westport, CT	0
BROOKFIELD MEDICAL SURGICAL SU	Brookfield, CT	0

Future Competition: Boehringer Ingelheim Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Boehringer Ingelheim Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)